Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients With Combined Pulmonary Fibrosis and Emphysema: Data From the INBUILD Trial

被引：0
|
作者：
Cottin, V. [1 ]
Flaherty, K. R. [2 ]
Inoue, Y. [3 ]
Valenzuela, C. [4 ]
Mueller, H. [5 ]
Rohr, K. B. [6 ]
Wells, A. U. [7 ,8 ]
机构：
[1] Claude Bernard Univ Lyon 1, Louis Pradel Hosp, Hosp Civils Lyon, Natl Reference Ctr Rare Pulm Dis,UMR 754, Lyon, France
[2] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI USA
[3] Natl Hosp Org, Clin Res Ctr, Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[4] Univ Autonoma Madrid, Hosp Univ Princesa, Madrid, Spain
[5] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[6] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[7] Imperial Coll, Natl Inst Hlth Res, Resp Biomed Res Unit, Royal Brompton & Harefield NHS Fdn Trust, London, England
[8] Imperial Coll, Natl Heart & Lung Inst, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2578
引用
收藏
页数：2
相关论文
共 50 条
  • [21] EFFECT OF CONTINUED TREATMENT WITH PIRFENIDONE FOLLOWING A ≥ 10% RELATIVE DECLINE IN PERCENT PREDICTED FORCED VITAL CAPACITY (%FVC) IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Wells, A. U.
    Albera, C.
    Costabel, U.
    Glaspole, I.
    Glassberg, M. K.
    Lancaster, L.
    Lederer, D. J.
    Pereira, C. A.
    Swigris, J. J.
    Day, B-M
    Chou, W.
    Nathan, S. D.
    THORAX, 2016, 71 : A178 - A178
  • [22] First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value
    Wim A. Wuyts
    Martin Kolb
    Susanne Stowasser
    Wibke Stansen
    John T. Huggins
    Ganesh Raghu
    Lung, 2016, 194 : 739 - 743
  • [23] The Effect Of Bronchodilators On Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis
    Assayag, D.
    Vittinghoff, E.
    Ryerson, C. J.
    Cocconcelli, E.
    Tonelli, R.
    Elicker, B.
    Golden, J.
    Jones, K. D.
    King, T. E.
    Koth, L. L.
    Lee, J. S.
    Ley, B.
    Wolters, P. J.
    Collard, H. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [24] EFFECT OF PIRFENIDONE ON ALL-CAUSE MORTALITY (ACM) AND FORCED VITAL CAPACITY (FVC) IN IDIOPATHIC PULMONARY FIBROSIS (IPF) PATIENTS WITH LOW FVC AND/OR LOW DLCO: ANALYSIS OF POOLED DATA FROM ASCEND AND CAPACITY
    Nathan, S. D.
    Costabel, U.
    Albera, C.
    Kirchgaessler, K. U.
    Chou, W.
    Noble, P. W.
    THORAX, 2017, 72 : A254 - A254
  • [25] Effect Of Pirfenidone On All-Cause Mortality (acm) And Forced Vital Capacity (FVC) In Idiopathic Pulmonary Fibrosis (ipf) Patients With Low FVC And/or Low Dlco: Analysis Of Pooled Data From Ascend And Capacity
    Nathan, S. D.
    Costabel, U.
    Albera, C.
    Kirchgassler, K. -U.
    Chou, W.
    Noble, P. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [26] Effect of Nintedanib on Categorical Changes in FVC in Patients with Progressive Fibrosing ILDs: Further Analyses of the INBUILD Trial
    Maher, Toby M.
    Cerri, Stefania
    Hallowell, Robert W.
    Koschel, Dirk
    Pope, Janet
    Tolle, Leslie
    Mueller, Heiko
    Rohr, Klaus B.
    Inoue, Yoshikazu
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 375 - 377
  • [27] Rate Of Decline In Forced Vital Capacity (FVC) In Amyotrophic Lateral Sclerosis (als) Patients
    Sriaroon, C.
    Elamin, E. M.
    Pothen, S.
    Barnett, S.
    White, K.
    Anderson, W. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [28] Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons
    Nathan, Steven D.
    Wanger, Jack
    Zibrak, Joseph D.
    Wencel, Mark L.
    Burg, Cindy
    Stauffer, John L.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (02) : 175 - 181
  • [29] Consistent Effect of Nintedanib on Reducing FVC Decline in Patients With or Without Honeycombing in the INPULSIS Trials of Idiopathic Pulmonary Fibrosis
    Case, Amy
    Capapey, Jorge
    Kimura, Toshio
    Raghu, Ganesh
    CHEST, 2015, 148 (04)
  • [30] FORCED VITAL CAPACITY IN PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY FIBROSIS: PREDICTORS OF MEANINGFUL DECLINE
    Nihtyanova, Svetlana I.
    Derrett-Smith, Emma C.
    Fonseca, Carmen
    Ong, Voon H.
    Denton, Christopher P.
    RHEUMATOLOGY, 2020, 59
12345